- Zacks•6 hours ago
Exelixis, Inc. (EXEL) is scheduled to report first-quarter 2017 results on May 1, after the market close.
- Business Wire•yesterday
Exelixis, Inc. today announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will provide an overview of the company at Deutsche Bank’s Health Care Conference taking place May 3-4 in Boston, MA.
- Motley Fool•2 days ago
Looking to buy biotech stocks? Here are 7 important things to know.
EXEL : Summary for Exelixis, Inc. - Yahoo Finance
Exelixis, Inc. (EXEL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||20.96 x 500|
|Ask||22.32 x 1000|
|Day's Range||21.45 - 22.27|
|52 Week Range||4.25 - 23.49|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-78.86|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|